New appointees to Board and Leadership team bring global strategic, operational and commercial experience from across the medical device sector. New headquarters and state-of-the-art manufacturing ...

Oxford, UK – 24 February 2026 – Amber Therapeutics today announced a series of updates to its business highlighting the significant progress ...

Through Nexalin America, the Company’s division dedicated to U.S. government engagement, the Company participated in advocacy ...

Breakthrough Preclinical Result in Epilepsy Treatment These findings strengthen our confidence as we progress toward ...

At the forefront of this shift is Nuropod, a U.S.-available, non-invasive, ear-worn vagus nerve stimulation wearable designed to help support reductions in symptoms associated with persistent fatigue, ...

As Valentine’s Day gifting trends continue to shift toward wellness-focused products, neuromodulation devices are ...

Brain Performance Technologies launches Interventional Psychiatry, expanding access to precision neuromodulation for ...

NEW YORK, Feb. 17, 2026 /PRNewswire/ -- The American Journal of Audiology has peer-reviewed and published the positive outcomes of U.S. tinnitus patients treated with Lenire, the only FDA approved ...

Lilac Biosciences, a biotechnology company spun out of the Giuliani RNA Center at Brown University, developing quantitative RNA-based analytical tools, announced a research collaboration with Soin ...

The Encora X1 utilizes proprietary algorithms to analyze a patient’s tremor in real time. It delivers targeted stimulation to the wrist, modulating the neural pathways responsible for the tremor. The ...

MIT researchers have created subcellular ‘circulatronic’ brain implants that can be administered via injection and self-implant to target a variety of ailments directly.

Flow’s headset is the first tDCS device approved by the FDA ...